Three new Ebola vaccines are being developed. An infectious disease expert explains
New funding has been secured to develop vaccines for the Bundibugyo Ebola virus, which is currently circulating in the DRC and Uganda. While existing vaccines target the Zaire strain, researchers are working to fast-track a solution for this specific variant.
Why it matters
Addressing specific viral strains is essential for controlling outbreaks and preventing further loss of life in affected regions.
Workers visit a patient in an isolation unit at an Ebola treatment center in Monigi in the Democratic Republic of Congo.
The article is a scientific explainer focused on public health and medical research.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in